Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
5.76
-0.50 (-7.99%)
Jul 18, 2025, 4:00 PM - Market closed

Actuate Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22
113155--
Enterprise Value
109142--
Last Close Price
5.767.96--
Quick Ratio
0.430.980.434.71
Current Ratio
0.461.050.434.71
Return on Equity (ROE)
---442.40%-
Return on Assets (ROA)
-413.44%-255.41%-132.96%-
Return on Capital (ROIC)
---279.06%-
Buyback Yield / Dilution
-766.91%-483.48%-18.54%-
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q